HomeNewsBusinessCoronavirus impact | Retail channels see sharp fall in growth: Nielsen India

Coronavirus impact | Retail channels see sharp fall in growth: Nielsen India

A survey with top industry leaders conducted by Nielsen revealed that supply chain and mobility issues have emerged as the biggest industry concern in the FMCG and retail space

April 17, 2020 / 17:25 IST
Story continues below Advertisement

Most retails channels, barring modern trade, have taken a hit in the last week of March on the back of novel coronavirus-led lockdown.

Nielsen India research revealed that traditional trade, e-commerce and cash and carry have seen a sharp fall in the last week of March.

Story continues below Advertisement

The only trade category that registered six percent growth in the last week of March was modern trade.

Of all the four channels, e-commerce was worst hit registering 64 percent fall in growth in the week-ending March 29. In comparison, during the first three weeks of March, it reported a 103 percent growth, 87 percent, 85 percent, respectively.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show